Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2

NCT05233410 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business decision; no safety concerns

Conditions

Chronic Hand Eczema (CHE)

Interventions

DRUG: Ruxolitinib cream
DRUG: Vehicle

Sponsor

Incyte Corporation